No news, no progress = low volume and no interest
Amyloid is hot, tau, SGMO are not. Will SGMO ever be in the right place at the right time and produce human clinical evidence that one of their products is commercially viable? Or, will they keep talking about the future, spending hundreds of millions per year on research, doing great partnerships that progress at a snail's pace and enroll 2-4 patients a year for their in-house trials. Or, will they sell the company. I don't think they want to sell and maybe there are no buyers. SGMO's a frustrating, serial underperformer!!!
I had a feeling when I started getting in deeper that SGMO might turn out like ACHN where I had to keep averaging down and finally after they removed the CEO and hired a turnaround team they sold at a low price...OK, just venting a little.